Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes

Experimental Dermatology

Volumn 12, Issue 6, 2003, Pages 761-771

  Rumpler, G ^a   Becker, B ^a   Hafner, C ^a   McClelland, M ^b   Stolz, W ^a   Landthaler, M ^a   Schmitt, R ^a   Bosserhoff, A ^c   Vogt, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b SIDNEY KIMMEL CANCER CENTER   (United States)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

cDNA arrays; Gene expression; Malignant melanoma; RNA fingerprinting (RAP PCR)

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BETA GALACTOSIDASE; CATHEPSIN; CATHEPSIN Z; COMPLEMENTARY DNA; CYTOCHROME B; DNA BINDING PROTEIN; EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 GAMMA; FOLIC ACID RECEPTOR 1; GLIA DERIVED NEXIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT LIKE PROTEIN; HEAT SHOCK PROTEIN 90; HLA ANTIGEN CLASS 2; INITIATION FACTOR 2; LAMININ BINDING PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; OSTEONECTIN; PHOSPHOLIPID TRANSFER PROTEIN; POLYADENYLIC ACID BINDING PROTEIN; PROTEIN; PROTEIN LYSINE 6 OXIDASE; PROTEINASE; RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SELENOPROTEIN; TUMOR PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; WILM TUMOR RELATED PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL CYCLE; DISEASE MODEL; DNA HYBRIDIZATION; DNA MICROARRAY; DNA TRANSCRIPTION; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROGENY; RNA FINGERPRINTING; TISSUE REPAIR;

ANIMALS; BLOTTING, NORTHERN; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA, COMPLEMENTARY; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HUMANS; MELANOMA; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0142084471     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2003.00082.x     Document Type: Article

References (46)

1. Castellano M, Parmiani G. Genes involved in melanoma: An overview of INK4a and other loci. Melanoma Res 1999: 9: 421-432.
2. Walker G J, Flores J F, Glendening J M, Lin A H, Markl I D, Fountain J W. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets. Genes Chromosomes Cancer 1998: 22: 157-163.
3. Soengas M S, Capodieci P, Polsky D et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001: 409: 207-211.
4. Iida J, Pei D, Kang T et al. Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen. J Biol Chem 2001: 276: 18786-18794.
5. Nestle FO. Dendritic cell vaccination for cancer therapy. Oncogene 2000: 19: 6673-6679.
6. Geertsen R, Hofbauer G, Kamarashev J, Yue F Y, Dummer R. Immune escape mechanisms in malignant melanoma. Int J Mol Med 1999: 3: 49-57.
7. Hess A R, Seftor E A, Gardner L M et al. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: Role of epithelial cell kinase (Eck/EphA2). Cancer Res 2001: 61: 3250-3255.
8. Friedl P, Bröcker E B, Zanker K S. Integrins, cell matrix interactions and cell migration strategies: Fundamental differences in leukocytes and tumor cells. Cell Adhes Commun 1998: 6: 225-236.
9. Muller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001: 410: 50-56.
10. Seftor E, Seftor R, Hendrix M. Selection of invasive and metastatic subpopulations from a heterogeneous human melanoma cell line. Biotechniques 1990: 9: 324-331.
11. Jacob K, Bosserhoff A, Wach F et al. Characterization of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones. Int J Cancer 1995: 60: 668-675.
12. Kobayashi H, Man S, MacDougall J, Graham C, Lu C, Kerbel R. Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine-resistant phenotype. Am J Pathol 1994: 144: 776-786.
13. Seftor R, Seftor E, Gehlsen K et al. Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 1992: 89: 1557-1561.
14. Liang P, Pardee A. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction [see comments]. Science 1992: 257: 967-971.
15. Byers R J, Hoyland J A, Dixon J, Freemont A J. Subtractive hybridization - Genetic takeaways and the search for meaning. Int J Exp Pathol 2000: 81: 391-404.
16. Welsh J, McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 1990: 18: 7213-7218.
17. Velculescu V, Zhang L, Vogelstein B, Kinzler K. Serial analysis of gene expression. Science 1995: 270: 484-487.
18. Schena M, Shalon D, Davis R, Brown P. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995: 270: 467-470.
19. Kim C J, Reintgen D S, Yeatman T J. The promise of microarray technology in melanoma care. Cancer Control 2002: 9: 49-53.
20. Vogt T M, Welsh J, Stolz W et al. RNA fingerprinting display UVB-specific disruption of transcriptional control in human melanocytes. Cancer Res 1997: 57: 3554-3561.
21. Becker B, Vogt T, Landthaler M, Stolz W. Detection of differentially regulated genes in keratinocytes by cDNA array hybridization: Hsp27 and other novel players in response to artificial ultraviolet radiation. J Invest Dermatol 2001: 116: 983-988.
22. Bertucci F, Houlgatte R, Benziane A et al. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 2000: 9: 2981-2991.
23. Duggan D J, Bittner M, Chen Y, Meltzer P, Trent J M. Expression profiling using cDNA microarrays. Nat Genet 1999: 21: 10-14.
24. Bittner M, Meltzer P, Chen Y et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000: 406: 536-540.
25. Clark E A, Golub T R, Lander E S, Hynes R O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000: 406: 532-535.
26. Gehlsen K R, Davis G E, Sriramarao P. Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis 1992: 10: 111-120.
27. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring. Harbor Laboratory Press, 1989.
28. Vogt T, Stolz W, Welsh J et al. Overexpression of Lerk-5/Eplg5 messenger RNA: A novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin Cancer Res 1998: 4: 791-797.
29. Bieche I, Nogues C, Paradis V et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000: 6: 452-459.
30. McClelland M, Ralph D, Cheng R, Wels J. Interactions among regulators of RNA abundance characterized using RNA fingerprinting by arbitrarily primed PCR. Nucleic Acids Res 1994: 22: 4419-4431.
31. Perucho M, Welsh J, Peinado M A, Ionov Y, McClelland M. Fingerprinting of DNA and RNA by arbitrarily primed polymerase chain reaction: Applications in cancer research. Methods Enzymol 1995: 254: 275-290.
32. Ralph D, McClelland M, Welsh J. RNA fingerprinting using arbitrarily primed PCR identifies differentially regulated RNAs in mink lung (Mv1Lu) cells growth arrested by transforming growth factor beta 1. Proc Natl Acad Sci USA 1993: 90: 10710-10714.
33. Motamed K. SPARC (Osteonectin/BM-40). Int J Biochem Cell Biol 1999: 31: 1363-1366.
34. Sage E H. Terms of attachment: SPARC tumorigenesis. Nat Med 1997: 3: 144-146.
35. Nishihira J. Macrophage migration inhibitory factor (MIF): Its essential role in the immune system and cell growth. J Interferon Cytokine Res 2000: 20: 751-762.
36. Repp A C, Mayhew E S, Apte S, Niederkorn J Y. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol 2000: 165: 710-715.
37. Santamaria I, Velasco G, Pendas A M, Fueyo A, Lopez-Otin C. Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and a unique chromosomal location. J Biol Chem 1998: 273: 16816-16823.
38. Ciechanover A, Orian A, Schwartz A L. The ubiquitin-mediated proteolytic pathway: Mode of action and clinical implications. J Cell Biochem 2000: 77 (Suppl. 34): 40-51.
39. Nicolaou K, Pfefferkorn J, Schuler F, Roecker A, Cao G, Casida J. Combinatorial synthesis of novel and potent inhibitors of NADH. ubiquinone oxidoreductase. Chem Biol 2000: 7: 979-992.
40. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J D. Molecular Biology of the Cell, 3rd edn. New York: Garland Publishing Inc., 1994.
41. Sager R. Expression genetics in cancer: Shifting the focus from DNA to RNA. Proc Natl Acad Sci USA 1997: 94: 952-955.
42. Ledda M F, Adris S, Bravo A I et al. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med 1997: 3: 171-176.
43. Ledda F, Bravo A I, Adris S, Bover L, Mordoh J, Podhajcer O L. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol 1997: 108: 210-214.
44. Ogawa H, Nishihira J, Sato Y et al. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 2000: 12: 309-314.
45. Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Commun 1999: 264: 751-758.
46. Fröhlich E, Schlagenhauff B, Möhrle M, Weber E, Klessen C, Rassner G. Activity, expression, and transcription rate of the cathepsin B, D, H, and L in cutaneous malignant melanoma. Cancer 2001: 91: 972-982.